Loading...
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Appreciation for genomic and immune heterogeneity in cancer has grown though the relationship of these factors to treatment response has not been thoroughly elucidated. To better understand this, we studied a large cohort of melanoma patients treated with targeted therapy or immune checkpoint blocka...
Na minha lista:
| Udgivet i: | NPJ Genom Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557036/ https://ncbi.nlm.nih.gov/pubmed/28819565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41525-017-0013-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|